Federal Register / Vol. 86, No. 42 / Friday, March 5, 2021 / Notices 12955 

healthequitytaskforce/ when this 

information becomes available. 

FOR FURTHER INFORMATION CONTACT: 

Samuel Wu, Designated Federal Officer 

for the Task Force; Office of Minority 

Health, Department of Health and 

Human Services, Tower Building, 1101 

Wootton Parkway, Suite 100, Rockville, 

Maryland 20852. 

Phone: 240–453–6173; email: 

COVID19HETF@hhs.gov. 

SUPPLEMENTARY INFORMATION: 

Background: COVID–19 Health Equity 

Task Force (Task Force) was established 

by Executive Order 13995, dated 

January 21, 2021. The Task Force is 

tasked with developing a set of 

recommendations to the President, 

through the Coordinator of the COVID– 

19 Response and Counselor to the 

President (COVID–19 Response 

Coordinator) for mitigating the health 

inequities caused or exacerbated by the 

COVID–19 pandemic and for preventing 

such inequities in the future. The Task 

Force shall submit a final report to the 

COVID–19 Response Coordinator 

addressing any ongoing health 

inequities faced by COVID–19 survivors 

that may merit a public health response, 

describing the factors that contributed to 

disparities in COVID–19 outcomes, and 

recommending actions to combat such 

disparities in future pandemic 

responses. 

The meeting is open to the public and 

will be live-streamed at www.hhs.gov/ 

live. A public comment session will be 

held during the meeting. Pre-registration 

is required to provide public comment 

during the meeting. To pre-register to 

attend or to provide public comment, 

please send an email to 

COVID19HETF@hhs.gov and include 

your name, title, and organization by 

close of business on Friday, March 19, 

2021. Comments will be limited to no 

more than three minutes per speaker 

and should be pertinent to the meeting 

discussion. Individuals are encouraged 

to provide a written statement of any 

public comment(s) for accurate minutetaking purposes. If you decide you 

would like to provide public comment 

but do not pre-register, you may submit 

your written statement by emailing 

COVID19HETF@hhs.gov no later than 

close of business Thursday, April 1, 

2021. Individuals who plan to attend 

and need special assistance, such as 

sign language interpretation or other 

reasonable accommodations, should 

contact: COVID19HETF@hhs.gov and 

reference this meeting. Requests for 

special accommodations should be 

made at least ten (10) business days 

prior to the meeting. 

Dated: March 1, 2021. 

Samuel Wu, 

Designated Federal Officer, COVID–19 Health 

Equity Task Force. 

[FR Doc. 2021–04605 Filed 3–4–21; 8:45 am] 

BILLING CODE 4150–29–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Heart, Lung, and Blood 

Institute; Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Heart, Lung, 

and Blood Institute Special Emphasis Panel; 

Career Development Program to Promote 

Diversity in Health Research (K01). 

Date: April 1, 2021. 

Time: 9:30 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6705 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Lindsay M. Garvin, Ph.D., 

Scientific Review Officer, Office of Scientific 

Review/DERA, National Heart, Lung, and 

Blood Institute, National Institutes of Health, 

6705 Rockledge Drive, Suite 208–Y, 

Bethesda, MD 20892, (301) 827–7911, 

lindsay.garvin@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.233, National Center for 

Sleep Disorders Research; 93.837, Heart and 

Vascular Diseases Research; 93.838, Lung 

Diseases Research; 93.839, Blood Diseases 

and Resources Research, National Institutes 

of Health, HHS) 

Dated: March 1, 2021. 

David W. Freeman, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–04523 Filed 3–4–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; RFA Panel: 

Co-Occurring Conditions, Data Science, and 

Clinical Trials Readiness in Down Syndrome. 

Date: March 25, 2021. 

Time: 9:00 a.m. to 1:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Maribeth Champoux, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3170, 

MSC 7848, Bethesda, MD 20892, 301–594– 

3163, champoum@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR 19–386 

Environmental Risks for Psychiatric 

Disorders: Biological Basis of 

Pathophysiology. 

Date: March 25, 2021. 

Time: 3:00 p.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Julius Cinque, MS, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5186, 

MSC 7846, Bethesda, MD 20892, (301) 435– 

1252, cinquej@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Mechanisms of Stress, Emotion, 

Health and Reward. 

Date: March 26, 2021. 

Time: 12:00 p.m. to 3:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Telephone Conference 

Call). 

Contact Person: Andrea B Kelly, Ph.D., 

Scientific Review Officer, Center for 


jbell on DSKJLSW7X2PROD with NOTICES
12956 Federal Register / Vol. 86, No. 42 / Friday, March 5, 2021 / Notices 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3182, 

MSC 7770, Bethesda, MD 20892, (301) 455– 

1761, kellya2@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Topics in Virology. 

Date: March 30–31, 2021. 

Time: 10:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Marci Scidmore, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3192, 

MSC 7808, Bethesda, MD 20892, 301–435– 

1149, marci.scidmore@nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; RFA–OD19– 

029: The Intersection of Sex and Gender 

Influences on Health and Disease. 

Date: March 30–31, 2021. 

Time: 10:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II ,6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Latha Meenalochana 

Malaiyandi, Ph.D., Scientific Review Officer, 

Center for Scientific Review, National 

Institutes of Health, 6701 Rockledge Drive, 

Room 812Q, Bethesda, MD 20892, (301) 435– 

1999, malaiyandilm@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Training in 

Veterinary and Comparative Medicine. 

Date: March 30, 2021. 

Time: 1:00 p.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Mark Caprara, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5156, 

MSC 7844, Bethesda, MD 20892, 301–613– 

5228, capraramg@mail.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: HIV/AIDS Related Behavioral 

Research. 

Date: March 30, 2021. 

Time: 1:00 p.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Pamela Jeter, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 10J08, 

Bethesda, MD 20892, (301) 435–2591, 

pamela.jeter@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: March 1, 2021. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–04516 Filed 3–4–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Toxicology Program Board of 

Scientific Counselors; Announcement 

of Meeting; Request for Comments 

AGENCY: National Institutes of Health, 

HHS. 

ACTION: Notice. 

SUMMARY: This notice announces the 

next meeting of the National Toxicology 

Program (NTP) Board of Scientific 

Counselors (BSC). The BSC, a federally 

chartered, external advisory group 

composed of scientists from the public 

and private sectors, will review and 

provide advice on programmatic 

activities. This meeting is a virtual 

meeting and is open to the public. 

Written comments will be accepted and 

registration is required to present oral 

comments. Information about the 

meeting and registration are available at 

https://ntp.niehs.nih.gov/go/165. 

DATES: 

Meeting: Scheduled for April 23, 

2021, 12:30 p.m.–5:00 p.m. Eastern 

Daylight Time (EDT). 

Written Public Comment 

Submissions: Deadline is April 16, 2021. 

Registration for Oral Comments: 

Deadline is April 16, 2021. 

ADDRESSES: 

Meeting Web page: The preliminary 

agenda, registration, and other meeting 

materials are available at https://

ntp.niehs.nih.gov/go/165. 

Virtual Meeting: The URL for viewing 

the virtual meeting will be provided on 

the meeting web page. 

FOR FURTHER INFORMATION CONTACT: Dr. 

Sheena Scruggs, Designated Federal 

Official for the BSC, Office of Liaison, 

Policy and Review, Division of NTP, 

NIEHS, P.O. Box 12233, K2–03, 

Research Triangle Park, NC 27709. 

Phone: 984–287–3355, Fax: 301–451– 

5759, Email: sheena.scruggs@nih.gov. 

Hand Deliver/Courier address: 530 

Davis Drive, Room K2130, Morrisville, 

NC 27560. 

SUPPLEMENTARY INFORMATION: The BSC 

will provide input to the NTP on 

programmatic activities and issues. The 

preliminary agenda topics include 

presentations from two of the Division 

of the National Toxicology Program 

(DNTP)’s research program areas. The 

preliminary agenda, roster of BSC 

members, background materials, public 

comments, and any additional 

information, when available, will be 

posted on the BSC meeting web page 

(https://ntp.niehs.nih.gov/go/165) or 

may be requested in hardcopy from the 

Designated Federal Official for the BSC. 

Following the meeting, summary 

minutes will be prepared and made 

available on the BSC meeting web page. 

Meeting Attendance Registration: The 

meeting is open to the public with time 

scheduled for oral public comments. 

Registration is not required to view the 

virtual meeting; the URL for the virtual 

meeting is provided on the BSC meeting 

web page (https://ntp.niehs.nih.gov/go/ 

165). TTY users should contact the 

Federal TTY Relay Service at 800–877– 

8339. Requests should be made at least 

five business days in advance of the 

event. 

Written Public Comments: NTP 

invites written public comments. 

Guidelines for public comments are 

available at https://ntp.niehs.nih.gov/ 

ntp/about_ntp/guidelines_public_

comments_508.pdf. 

The deadline for submission of 

written comments is April 16, 2021. 

Written public comments should be 

submitted through the meeting web 

page. Persons submitting written 

comments should include name, 

affiliation, mailing address, phone, 

email, and sponsoring organization (if 

any). Written comments received in 

response to this notice will be posted on 

the NTP web page, and the submitter 

will be identified by name, affiliation, 

and sponsoring organization (if any). 

Oral Public Comment Registration: 

The agenda allows for two formal public 

comment periods—one comment period 

for each program area (up to 3 

commenters, up to 5 minutes per 

speaker, per topic). Persons wishing to 

make an oral comment are required to 

register online at https://

ntp.niehs.nih.gov/go/165 by April 16, 

2021. Oral comments will be received 

only during the formal comment periods 

indicated on the preliminary agenda. 

Oral comments will only be by 

teleconference line. The access number 

for the teleconference line will be 

provided to registrants by email prior to 

the meeting. Registration is on a firstcome, first-served basis. Each 

organization is allowed one time slot 

per topic. After the maximum number of 

speakers per comment period is 

exceeded, individuals registered to 

provide oral comment will be placed on 

a wait list and notified should an 

opening become available. Commenters 

will be notified approximately one week 


jbell on DSKJLSW7X2PROD with NOTICES